An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early ...

Nearly a year after Coherus BioSciences’ on-body injector for Udenyca was rejected over external production issues, a ...

As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...

Equipped with a $200 million investment led by Bain’s Life Science arm, Serán has set its sights on the build-out of its ...

The partnership is slated to add work at Kincell's site in Gainesville, Florida, the company said in a Sept. 16 press release ...

Three months after a jury awarded $260 million to an Oregon woman who claimed her use of Johnson’s Baby Powder caused her to ...

New biologics such as GSK's Benlysta and AstraZeneca's Saphnelo, along with off-label drugs, have been the mainstay for ...

The same set of clinical data on Cabometyx and Tecentriq in prostate cancer has led to two distinct regulatory plans between ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get ...

Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver ...

Three years after establishing an immunology unit, Eli Lilly has gained its third FDA approval in the specialty area as the U ...

Sandoz and United Therapeutics’ years-long dispute over a generic to pulmonary arterial hypertension med treprostinil has ...